April 2014—PAML and CellNetix launched a joint venture anatomic pathology reference laboratory separately branded as Symbiodx. A major focus of this venture will be on molecular oncology with a broad offering of molecular tests, including next-generation sequencing, IHC, flow cytometry, and cytogenetics.
Read More »